Cited 0 times in
A phase Ib, open-label study evaluating the safety and efficacy of ipatasertib + rucaparib in patients with metastatic castration-resistant prostate cancer
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 신상준 | - |
dc.date.accessioned | 2023-06-02T00:38:18Z | - |
dc.date.available | 2023-06-02T00:38:18Z | - |
dc.date.issued | 2022-02 | - |
dc.identifier.issn | 0732-183X | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/194318 | - |
dc.description.statementOfResponsibility | restriction | - |
dc.language | English | - |
dc.publisher | American Society of Clinical Oncology | - |
dc.relation.isPartOf | JOURNAL OF CLINICAL ONCOLOGY | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.title | A phase Ib, open-label study evaluating the safety and efficacy of ipatasertib + rucaparib in patients with metastatic castration-resistant prostate cancer | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Internal Medicine (내과학교실) | - |
dc.contributor.googleauthor | David William Pook | - |
dc.contributor.googleauthor | Daniel M. Geynisman | - |
dc.contributor.googleauthor | Joan Carles | - |
dc.contributor.googleauthor | Filippo G. De Braud | - |
dc.contributor.googleauthor | Anthony M. Joshua | - |
dc.contributor.googleauthor | Jose Luis Perez-Gracia | - |
dc.contributor.googleauthor | Casilda Llácer Pérez | - |
dc.contributor.googleauthor | Sang Joon Shin | - |
dc.contributor.googleauthor | Bruno Fang | - |
dc.contributor.googleauthor | Minal A. Barve | - |
dc.contributor.googleauthor | Marco Maruzzo | - |
dc.contributor.googleauthor | Sergio Bracarda | - |
dc.contributor.googleauthor | Miso Kim | - |
dc.contributor.googleauthor | Yannick Kerloeguen | - |
dc.contributor.googleauthor | Jorge Daniel Gallo | - |
dc.contributor.googleauthor | Sophia Maund | - |
dc.contributor.googleauthor | Adam Harris | - |
dc.contributor.googleauthor | Kuan-Chieh Huang | - |
dc.contributor.googleauthor | Dhruvitkumar S. Sutaria | - |
dc.contributor.googleauthor | Howard Gurney | - |
dc.identifier.doi | 10.1200/JCO.2022.40.6_suppl.095 | - |
dc.contributor.localId | A02105 | - |
dc.relation.journalcode | J01331 | - |
dc.identifier.eissn | 1527-7755 | - |
dc.identifier.url | https://ascopubs.org/doi/10.1200/JCO.2022.40.6_suppl.095 | - |
dc.contributor.alternativeName | Shin, Sang Joon | - |
dc.contributor.affiliatedAuthor | 신상준 | - |
dc.citation.volume | 40 | - |
dc.citation.number | 6 | - |
dc.citation.startPage | S95 | - |
dc.identifier.bibliographicCitation | JOURNAL OF CLINICAL ONCOLOGY, Vol.40(6) : S95, 2022-02 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.